Loading
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
NASDAQHealthcareBiotechnology
Latest quote
$40.42
−$0.33 · -0.81%
Previous close
$40.42
−$0.33 · -0.81%
Regular session · ET · Market data may be delayed.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Day range
Current $40.42
52-week range
Current $40.42
Regular session · ET · Market data may be delayed.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Day range
Current $40.42
52-week range
Current $40.42
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Research and development | 125.58M USD | 100.83M USD |
| Selling, general, and administrative | 26.5M USD | 25.3M USD |
| Operating expenses | 152.08M USD | 126.13M USD |
| Interest income | 3.39M USD | 6.41M USD |
| Interest expense | 1.52M USD | 1.49M USD |
| Depreciation and amortization | 2.5M USD | 2.1M USD |
| Operating income | −152.08M USD | −126.13M USD |
| Net income | −145.89M USD | −117.91M USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$40.00
1.04% downsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI38.09M0.00%2.3T USD0.03%$379.73-0.32%
Vanguard Morningstar Small-Cap ETFVB27.5M0.01%183.4B USD0.03%$300.01+0.05%
Vanguard Morningstar Small-Cap Value ETFVBR8.73M0.01%68.3B USD0.05%$247.11+0.08%
Vanguard Morningstar Small-Cap Growth ETFVBK7.87M0.02%43.8B USD0.05%$349.44+0.01%
Fidelity Blue Chip Growth ETFFBCG2.25M0.03%6.92B USD0.57%$62.36+0.39%
Fidelity Nasdaq Composite Index ETFONEQ1.13M0.01%10.35B USD0.21%$104.46-0.29%
Tema Healthcare AI ETFHLTH323.16K3.44%—0.75%$28.5059-0.75%
Innovator U.S. Small Cap Managed Floor ETFRFLR112.04K0.12%96.66M USD0.89%$32.785+0.33%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Morningstar Small-Cap Growth ETFVBKFidelity Blue Chip Growth ETFFBCGFidelity Nasdaq Composite Index ETFONEQTema Healthcare AI ETFHLTHInnovator U.S. Small Cap Managed Floor ETFRFLRAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
